Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors

Clinical trial NCT06380660 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06380660
Sponsor: Acerand Therapeutics (Shanghai) Limited
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult BRCA1 Mutation BRCA2 Mutation Ovarian Cancer Breast Cancer Prostate Cancer

Start date: 2024-03-22
Primary completion: 2028-12-21
Enrollment: 298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.